5th Global Conference on Myositis | Pittsburgh, (Pennsylvania, US), 13-16 March 2024
Location:
Description:
The 5th Global Conference on Myositis will be held in a Pittsburgh, Pennsylvania US. This important event will offer a unique opportunity to meet and discuss the latest advancements in myositis from different perspectives. Details
Date:
16-JAN-2023
Title:
COVID-19 Pediatric Rheumatology Survey by the PReS EMERGE group
Location:
Description:
COVID-19 pandemic has been a global health problem threatening millions of lives worldwide. In order to learn about the way the COVID-19 pandemic has changed our pediatric rheumatology practice, just take five minutes and complete a short survey coordinated by the PReS EMERGE group! Details
Date:
02-DEC-2022
Title:
ISSAID annual meeting | Toronto, 15-18 May 2023
Location:
Description:
The next annual meeting of the International Society of Systemic Auto-Inflammatory Diseases (ISSAID) will be held in Toronto, from 15 to 18 May 2023.
Abstract submission is open until Monday 28 February 2023. Details
Date:
28-MAR-2022
Title:
GCOM 2024: Call for proposals!
Location:
Description:
The GCOM conference as the premier conference for myositis takes place every two years. Following this year's meeting in Prague, the GCOM 2024 Interim Steering Committee is calling for proposals to host the fifth GCOM meeting in 2024. Deadline for submission is 11 May 2022! Details
Date:
20-JUL-2021
Title:
The new iMyoS website of the International Myositis Society
Location:
Description:
We welcome all of you to visit https://imyos.org and join us in exploring this new window of opportunity for a better future of how to diagnose and treat myositis and how to live with it. Details
Date:
05-JUL-2021
Title:
Global survey on biosimilar medications
Location:
Description:
You are invited to complete a global survey to investigate the perspective of pediatric rheumatologists worldwide in terms of biosimilar preference, knowledge and acceptance. Details
Date:
10-MAY-2021
Title:
PReS 2021 e-congress | Time is running out to submit your latest research!
Location:
Description:
On behalf of PReS, we invite you to share your latest findings with a global network of professionals during the PReS 2021 e-congress. Accepted abstracts will be published in the Supplement of the Pediatric Rheumatology Journal by BMC and will be available on the Congress website two weeks prior to the event.
|| Abstract Submission Deadline: 13 May 2021, 23:59 CET ||
Submit your findings here: https://www.pres.eu/pres2021/abstracts.html Details
Date:
23-OCT-2019
Title:
PReS/PRINTO collaboration | Annual calls for projects within the PReS Working Parties 2.0
Location:
Description:
With the aim of expanding the research activities of PReS, the Council envisaged a novel format of projects based on a tight collaboration with PRINTO. This novel PReS/PRINTO collaboration will consist in annual calls for projects within the PReS Working Parties 2.0 (WP2.0) and with the technical assistance from PRINTO. Details
Date:
06-DEC-2018
Title:
PRES Vaccination Working Party: the study on Safety of MMR booster in children treated with biologic therapy and DMARDs / Methotrexate is initiated
Location:
Description:
The study on safety of MMR booster in children treated with biologic therapy and DMARDs / Methotrexate was initiated in PRES Vaccination Working Party. If you are aware of any patients with rheumatic disease treated with biologic therapy and / or methotrexate that received booster MMR while on therapy, please join the PRES Vaccination WP! Details
Date:
07-SEP-2017
Title:
Collaboration of PRINTO with the ERN RITA
Location:
Description:
European Reference Networks (ERN) are involving virtual networks healthcare providers across Europe supported by the European Commission. To review a patient’s diagnosis and treatment, ERN coordinators will convene a “virtual” advisory board of medical specialists across different disciplines, using a dedicated IT platform and telemedicine tools. This way it is the medical knowledge and expertise that travel, who have the rather than the patients’ comfort of staying in their supportive home environments. Details